| Product Code: ETC9937953 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market - Industry Life Cycle |
3.4 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market - Porter's Five Forces |
3.5 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
4 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions |
4.2.2 Growing adoption of artificial intelligence technologies in healthcare |
4.2.3 Rising investment in research and development in the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 Lack of regulatory clarity and guidelines for AI applications in drug discovery |
4.3.2 Data privacy and security concerns |
4.3.3 High initial investment costs for implementing AI technologies |
5 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Trends |
6 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market, By Types |
6.1 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing, 2021- 2031F |
6.1.4 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Preclinical Testing, 2021- 2031F |
6.1.5 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.2.4 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Metabolic DiseasesInfectious Diseases, 2021- 2031F |
6.2.6 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market, By Component |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.3.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Hardware, 2021- 2031F |
6.3.4 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
7 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Export to Major Countries |
7.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Imports from Major Countries |
8 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Key Performance Indicators |
8.1 Percentage increase in successful drug discoveries using AI algorithms |
8.2 Number of collaborations between pharmaceutical companies and AI technology providers |
8.3 Improvement in drug development timelines attributed to AI integration |
8.4 Rate of adoption of AI tools and platforms in drug discovery research |
8.5 Number of AI-based drug discovery patents filed or approved |
9 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market - Opportunity Assessment |
9.1 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
10 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market - Competitive Landscape |
10.1 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Artificial Intelligence In Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here